Literature DB >> 26435407

Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.

M M Lauridsen1, L Poulsen2, C K Rasmussen2, M Høgild2, M K Nielsen2, O B Schaffalitzky de Muckadell3, H Vilstrup4.   

Abstract

Many chronic medical conditions are accompanied by cognitive disturbances but these have only to a very limited extent been psychometrically quantified. An exception is liver cirrhosis where hepatic encephalopathy is an inherent risk and mild forms are diagnosed by psychometric tests. The preferred diagnostic test battery in cirrhosis is often the Continuous Reaction Time (CRT) and the Portosystemic Encephalopathy (PSE) tests but the effect on these of other medical conditions is not known. We aimed to examine the effects of common chronic (non-cirrhosis) medical conditions on the CRT and PSE tests. We studied 15 patients with heart failure (HF), 15 with end stage renal failure (ESRF), 15 with dysregulated type II diabetes (DMII), 15 with chronic obstructive pulmonary disease (COPD), and 15 healthy persons. We applied the CRT test, which is a 10-min computerized test measuring sustained attention and reaction time stability and the PSE test, which is a paper-pencil test battery consisting of 5 subtests. We found that a high fraction of the patients with HF (8/15, 0.002) or COPD (7/15, p = 0.006) had pathological CRT test results; and COPD patients also frequently had an abnormal PSE test result (6/15, p < 0.0001). Both tests were unaffected by ESRF and DMII. Half of the patients with HF or COPD had psychometrically measurable cognitive deficits, whereas those with ESRF or DMII had not. This adds to the understanding of the clinical consequences of chronic heart- and lung disease, and implies that the psychometric tests should be interpreted with great caution in cirrhosis patients with heart- or lung comorbidity.

Entities:  

Keywords:  COPD; Comorbidity; Diabetes; Heart failure; Liver cirrhosis; Minimal hepatic encephalopathy; PHES; Reaction time; Renal failure

Mesh:

Year:  2015        PMID: 26435407     DOI: 10.1007/s11011-015-9741-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  31 in total

1.  Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure.

Authors:  Ponrathi Athilingam; Jan Moynihan; Leway Chen; Rita D'Aoust; Maureen Groer; Kevin Kip
Journal:  Congest Heart Fail       Date:  2012-10-12

Review 2.  Cognitive function in COPD.

Authors:  J W Dodd; S V Getov; P W Jones
Journal:  Eur Respir J       Date:  2010-04       Impact factor: 16.671

3.  Neuropsychological aspects of portal-systemic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

4.  Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis.

Authors:  Mette Munk Lauridsen; Henning Grønbæk; Esben B Næser; Steffen T Leth; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2012-05-22       Impact factor: 3.584

5.  Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial.

Authors:  Marjolein Huijts; Robert J van Oostenbrugge; Annelien Duits; Thilo Burkard; Stefano Muzzarelli; Micha T Maeder; Ruth Schindler; Matthias E Pfisterer; Hans-Peter Brunner-La Rocca
Journal:  Eur J Heart Fail       Date:  2013-02-05       Impact factor: 15.534

Review 6.  Comorbidity in cirrhosis.

Authors:  Peter Jepsen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

7.  Subclinical hepatic encephalopathy impairs daily functioning.

Authors:  M Groeneweg; J C Quero; I De Bruijn; I J Hartmann; M L Essink-bot; W C Hop; S W Schalm
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

8.  The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control.

Authors:  Rebecca K West; Ramit Ravona-Springer; James Schmeidler; Derek Leroith; Keren Koifman; Elizabeth Guerrero-Berroa; Rachel Preiss; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann; Michal Schnaider-Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2014-01-23       Impact factor: 4.105

Review 9.  Cognitive impairment in heart failure patients.

Authors:  Laura Leto; Mauro Feola
Journal:  J Geriatr Cardiol       Date:  2014-12       Impact factor: 3.327

10.  Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Erin Moshier; James Godbold; Mary Sano; Derek Leroith; Sterling Johnson; Rachel Preiss; Keren Koifman; Hadas Hoffman; Jeremy M Silverman; Michal Schnaider Beeri
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more
  6 in total

1.  Globus pallidus MR signal abnormalities in children with chronic liver disease and/or porto-systemic shunting.

Authors:  Sylviane Hanquinet; Claire Morice; Delphine S Courvoisier; Vladimir Cousin; Mehrak Anooshiravani; Laura Merlini; Valérie A McLin
Journal:  Eur Radiol       Date:  2017-04-06       Impact factor: 5.315

Review 2.  Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

Authors:  Simon Johannes Gairing; Eva Maria Schleicher; Christian Labenz
Journal:  Metab Brain Dis       Date:  2022-08-24       Impact factor: 3.655

3.  Frequency of minimal hepatic encepalopathy in illeterate patients with compensated cirrhosis.

Authors:  Bader Faiyaz Zuberi; Haris Alvi; Faisal Faiyaz Zuberi; Tazeen Rasheed; Zunaira Nawaz
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

4.  Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.

Authors:  Christian Labenz; Gerrit Toenges; Jörn M Schattenberg; Michael Nagel; Yvonne Huber; Jens U Marquardt; Joachim Labenz; Peter R Galle; Marcus-Alexander Wörns
Journal:  Clin Transl Gastroenterol       Date:  2020-06       Impact factor: 4.396

5.  Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.

Authors:  Charlotte W Wernberg; Ove B Schaffalitzky de Muckadell; Hendrik Vilstrup; Mette M Lauridsen
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

6.  Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy.

Authors:  Mette Munk Lauridsen; Peter Jepsen; Charlotte Wilhelmina Wernberg; Ove B Schaffalitzky de Muckadell; Jasmohan S Bajaj; Hendrik Vilstrup
Journal:  Hepatol Commun       Date:  2020-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.